Adherium Limited

ADR

Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-26. The firm is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.

Adslot Ltd.

ADS

Adslot Ltd. engages in the provision of trading technology and services solutions. The company is headquartered in Melbourne, Victoria. Its principal activities include Trading Technology and Services. Trading Technology comprises Adslot Media, a global media trading technology platform, and Symphony, a workflow automation technology for media agencies. Services comprise digital marketing services provided by the Company's Webfirm division and project-based customization of Trading Technology. Adslot Media is an independent programmatic guaranteed technology that scales publisher-direct media buying through a direct connection with publisher ad servers. Symphony is the buying and planning workflow platform for media agencies. Symphony manages every step of the media buying life cycle. Adslot and Symphony provides end-to-end media planning, buying, and selling management for the advertising industry. The company operates in North America, Europe, and Asia Pacific.

Anteotech Ltd

ADO

AnteoTech Ltd. engages in the development, manufacturing, and distribution of life sciences, clinical diagnostics and bio-separations products and services. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Company’s lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The firm has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.